Sigma-Aldrich Investor Relations Sigma-Aldrich Investor Home Home Sigma-Aldrich home page



Investor Relations

Corporate Profile

Sigma-Aldrich, a leading Life Science and Technology company focused on enhancing human health and safety, manufactures and distributes 230,000 chemicals, biochemicals and other essential products and 40,000 equipment products to more than 1.4 million customers globally in research and applied labs as well as in industrial and commercial markets.  With three distinct business units – Research, Applied and SAFC Commercial – Sigma-Aldrich is committed to enabling science to improve the quality of life.  The Company operates in 37 countries, has approximately 9,000 employees worldwide and had sales of $2.7 billion in 2013.  For more information about Sigma-Aldrich, please visit its website at www.sigma-aldrich.com.

Recent Releases

Nov 4, 2014
Sigma-Aldrich Completes Acquisition of Cell Marque

Nov 3, 2014
Sigma-Aldrich Corporation Announces Filing Of Definitive Proxy Statement And Date Of Special Meeting Of Stockholders

Oct 29, 2014
SAFC Launches New Protein Quality Supplement to Increase N-linked Glycosylation

View all releases »


 

© 2014 Sigma-Aldrich Co. Reproduction forbidden without permission.
Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich, Inc. Best viewed in IE5 or higher